Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamar Lasky

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Pharmacoepidemiology and Drug Safety|February 25, 2016
Current needs in pediatric pharmacoepidemiologyTamar Lasky, Al Artaman, Angela S Czaja, et al.
Pharmacoepidemiology and Drug Safety|August 5, 2025
Evaluating the Impact of Data Standardization on Real-World DataElizabeth M Garry, Aidan Baglivo, Priya Govil, et al.
Clinical Therapeutics|October 26, 2006
Criteria supporting the study of drugs in the newbornRobert M Ward, William E Benitz, Daniel K Benjamin, et al.
Drugs - Real World Outcomes|March 1, 2020
Real-World Evidence to Assess Medication Safety or Effectiveness in Children: Systematic ReviewTamar Lasky, Bruce Carleton, Daniel B Horton, et al.
Pharmacoepidemiology and Drug Safety|January 13, 2025
Characterization of SARS-CoV-2 Diagnostic Tests and Liver Function Tests Among Patients With COVID-19 Diagnosed in Outpatient Settings Using Administrative Healthcare Data and Data From Commercial LaboratoriesAyad K Ali, Aidan Baglivo, Priya Govil, et al.
Plos One|September 26, 2022
Describing characteristics and treatment patterns of patients hospitalized with COVID-19 by race and ethnicity in a national RWD during the early months of the pandemicSarah E Vititoe, Imaani J Easthausen, Tamar Lasky, et al.
The Pediatric Infectious Disease Journal|February 8, 2006
Population-based incidence of infection with selected bacterial enteric pathogens in children younger than five years of age, 1996-1998Kathleen M Koehler, Tamar Lasky, Sara B Fein, et al.
Pharmacoepidemiology and Drug Safety|April 4, 2022
Categorization of COVID-19 severity to determine mortality riskElizabeth M Garry, Andrew R Weckstein, Kenneth Quinto, et al.
Epidemiology (Cambridge, Mass.)|September 25, 2025
Illustrating an Adaptive Prespecification Framework for Observational Research: Target Trial Emulations Comparing Immunomodulator Treatments for COVID-19Andrew R Weckstein, Vera Frajzyngier, Sarah E Vititoe, et al.
Open Forum Infectious Diseases|July 27, 2023
A Descriptive Cohort Study of Drug Utilization Patterns Among Patients Hospitalized With Coronavirus Disease 2019 in the United States, January 2021-February 2022Sarah E Vititoe, Priya Govil, Aidan Baglivo, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Pharmacoepidemiology and Drug Safety|February 25, 2016
Current needs in pediatric pharmacoepidemiologyTamar Lasky, Al Artaman, Angela S Czaja, et al.
Pharmacoepidemiology and Drug Safety|August 5, 2025
Evaluating the Impact of Data Standardization on Real-World DataElizabeth M Garry, Aidan Baglivo, Priya Govil, et al.
Clinical Therapeutics|October 26, 2006
Criteria supporting the study of drugs in the newbornRobert M Ward, William E Benitz, Daniel K Benjamin, et al.
Drugs - Real World Outcomes|March 1, 2020
Real-World Evidence to Assess Medication Safety or Effectiveness in Children: Systematic ReviewTamar Lasky, Bruce Carleton, Daniel B Horton, et al.
Pharmacoepidemiology and Drug Safety|January 13, 2025
Characterization of SARS-CoV-2 Diagnostic Tests and Liver Function Tests Among Patients With COVID-19 Diagnosed in Outpatient Settings Using Administrative Healthcare Data and Data From Commercial LaboratoriesAyad K Ali, Aidan Baglivo, Priya Govil, et al.
Plos One|September 26, 2022
Describing characteristics and treatment patterns of patients hospitalized with COVID-19 by race and ethnicity in a national RWD during the early months of the pandemicSarah E Vititoe, Imaani J Easthausen, Tamar Lasky, et al.
The Pediatric Infectious Disease Journal|February 8, 2006
Population-based incidence of infection with selected bacterial enteric pathogens in children younger than five years of age, 1996-1998Kathleen M Koehler, Tamar Lasky, Sara B Fein, et al.
Pharmacoepidemiology and Drug Safety|April 4, 2022
Categorization of COVID-19 severity to determine mortality riskElizabeth M Garry, Andrew R Weckstein, Kenneth Quinto, et al.
Epidemiology (Cambridge, Mass.)|September 25, 2025
Illustrating an Adaptive Prespecification Framework for Observational Research: Target Trial Emulations Comparing Immunomodulator Treatments for COVID-19Andrew R Weckstein, Vera Frajzyngier, Sarah E Vititoe, et al.
Open Forum Infectious Diseases|July 27, 2023
A Descriptive Cohort Study of Drug Utilization Patterns Among Patients Hospitalized With Coronavirus Disease 2019 in the United States, January 2021-February 2022Sarah E Vititoe, Priya Govil, Aidan Baglivo, et al.
Pageof 4